REPLIMUNE GROUP, INC. Revenue Breakdown
No Revenue Breakdown for REPL on this site yet.
- 2018-12-31: Others Not split by product$0.00; Total revenue $0.00.
- 2018-09-30: Others Not split by product$0.00; Total revenue $0.00.
- 2018-06-30: Others Not split by product$0.00; Total revenue $0.00.
Source checked: the stored Revenue Breakdown page for REPL.
Revenue by product
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2018-12-31 | Not split by product $0.00 | $0.00 |
| 2018-09-30 | Not split by product $0.00 | $0.00 |
| 2018-06-30 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |